An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: An exploratory study

Cancer Nursing

Volumn 36, Issue 1, 2013, Pages 18-28

  Spoelstra, Sandra L ^a   Given, Barbara A ^a   Given, Charles W ^b   Grant, Marcia ^c   Sikorskii, Alla ^a   You, Mei ^a   Decker, Veronica ^d  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

Adherence; Chemotherapy; Intervention; Oral agent; Symptoms

Indexed keywords

ANTINEOPLASTIC AGENT; PRESCRIPTION DRUG;

ADULT; ANXIETY; APPETITE; ARTICLE; AUTOMATED VOICE RESPONSE SYSTEM; AUTOMATION; CANCER CHEMOTHERAPY; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NAUSEA; PAIN; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOM; VOMITING; WEAKNESS;

ADMINISTRATION, ORAL; ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TELEMEDICINE;

EID: 84871535514     PISSN: 0162220X     EISSN: 15389804     Source Type: Journal    
DOI: 10.1097/NCC.0b013e3182551587     Document Type: Article

References (34)

1. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94(9):652-661.
2. DeMario MD, Ratain MJ. Oral chemotherapy: rationale and future directions. J Clin Oncol. 1998;16(7):2557-2567.
3. Bartel SB. Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm. 2007;64:S8YS14.
4. Chan A, Tan SH, Wong CM, Yap KY, Ko Y. Clinically significant drug-to-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists. Clin Ther. 2009; 31:2379-2386.
5. Jacobson JO, Polovich M, McNiff KK, et al. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. Oncology Nursing Forum. 2009;36(6):1-8.
6. Sharma S, Saltz L. Oral chemotherapeutic agents for colorectal cancer. The Oncologist. 2000;5:99-107.
7. Given C, Given B, Rahbar M, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. J Clin Oncol. 2004;22(3):507-516.
8. Given B, Given C, Sikorskii A. Deconstruction of a nursing intervention to examine the mechanism of action. Oncol Nurs Forum. 2007;34(1):199.
9. Given CW, Given B, Azzouz F, Kozachik S, Stommel M. Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. J Pain Symptom Manage. 2001;21(6):456-466.
10. Sikorskii A, Given CW, Given B, et al. Symptom management for cancer patients: a trial comparing two multimodal interventions. J Pain Symptom Manage. 2007;34(3):253-264.
11. Given B, Given C, Sikorskii A, et al. Establishing mild, moderate, and severe scores for cancer related symptoms: how consistent and clinically meaningful are interference based severity cut points? J Pain Symptom Manage. 2008;35(2):126-135.
12. Ockene IS, Hayman LL, Pasternak RC, Schron E, Dunbar-Jacob J. Task force #4Vadherence issues and behavior changes: achieving a long-term solution. 33rd Bethesda Conference. J Am Coll Cardiol. 2002;40(4): 630-640.
13. Insel K, Morrow D, Brewer B, Figueredo A. Executive function, working memory, and medication adherence among older adults. J Gerontol B Psychol Sci Soc Sci. 2006;61(2):P102YP107.
14. Insel KC, Reminger SL, Hsiao CP. The negative association of independent personality and medication adherence. J Aging Health. 2006; 18(3):407-418.
15. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42(3):200-209.
16. Given BA, Spoelstra SL, Grant M. The Challenges of Oral Agents as Antineoplastic Treatments. Seminars in Oncology Nursing. 2011;27(2): 93-103.
17. Spoelstra S, Given BA, Given CW, Grant M. Policy Implications of Oral Agents. Seminars in Oncology Nursing. 2011;27(2):161-165.
18. Spoelstra S, Given CW. Assessment and Measurement of Adherence to Oral Antineoplastic Agents. Seminars in Oncology Nursing. 2011;27(2):116-132.
19. Cramer JA, Roy A, Burrell RA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-47.
20. Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30(7):33-43.
21. Weingart SN, Brown E, Bach PB, et al. NCCN task force report: oral chemotherapy. J Natl Compr Cancer Netw. 2008;6(Suppl 3):S1YS14.
22. Grunfeld EA, Hunter MS, Sikka P, et al. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns. 2005;59:97-102.
23. Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602-606.
24. Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26(4):556-562.
25. Given B, Given CW, Sikorskii A, Jeon S, Sherwood P, Rahbar M. The impact of providing symptom management assistance on caregiver reaction: results of a randomized trial. J Pain Symptom Manage. 2006;32(5):433-443.
26. Anastasia PJ, Blevins M. Outpatient chemotherapy: telephone triage for symptom management. Oncol Nurs Forum. 1997;24(1):13-21.
27. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008; CD000011(2).
28. Lee CR, Nicholson PW, Ledermann JA, et al. Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer. Eur J Gynaecol Oncol. 1996;17:99-103.
29. Hollywood E, Semple D. Nursing strategies for patients on oral chemotherapy. Oncology (Williston Park). 2001;15(1 [Suppl 2]):37-39 disc 40.
30. Given C, Given B, Sikorskii A, et al. Deconstruction of nurse-delivered patient self-management interventions for symptom management: factors related to delivery enactment and response. Ann Behav Med. 2010; 40:99-113.
31. Given CW, Given BA, Stommel M. The impact of age, treatment, and symptoms on the physical and mental health of cancer patients. A longitudinal perspective. Cancer. 1994;74(Suppl 7):2128-2138.
32. Given C, Given B, Rahbar M, Jeon S, et al. Does a symptom management intervention affect depression among cancer patients: results from a clinical trial. Psychooncology. 2004;13(11):818-830.
33. Armitage P. Exclusions, Losses to Follow-up and Withdrawals in Clinical Trials. New York: Marcie Dekker, 1983.
34. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348(10):883-890.